Unraveling the Epigenetic Tapestry: Decoding the Impact of Epigenetic Modifications in Hidradenitis Suppurativa Pathogenesis

• Published in: Genes Vol. 15; no. 1; p. 38
• Main Authors: Nardacchione, Elena Maria, Tricarico, Paola Maura, Moura, Ronald, d’Adamo, Adamo Pio, Thasneem, Ayshath, Suleman, Muhammad, Marzano, Angelo Valerio, Crovella, Sergio, Moltrasio, Chiara
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 26.12.2023
• Subjects: Acetylation; Adalimumab; Adult; adulthood; Apoptosis; B cells; Development and progression; Disease; disease course; disease progression; DNA methylation; Epigenesis, Genetic; Epigenetic inheritance; Epigenetics; Gene expression; Genes; Genetic engineering; Hidradenitis Suppurativa - genetics; Histone Code; Histones; Homeostasis; host specificity; Humans; Inflammation; Influence; Methylation; MicroRNA; MicroRNAs; MicroRNAs - genetics; miRNA; Molecular modelling; Pathogenesis; Proteins; Puberty; Skin; Skin diseases; Tumor necrosis factor-TNF; Vorinostat; microRNAs; acne inversa; methylation; long non-coding-RNAs; hidradenitis suppurativa; histone modifications; epigenetics
• ISSN: 2073-4425; 2073-4425
• DOI: 10.3390/genes15010038

Hidradenitis suppurativa (HS) is a chronic autoinflammatory skin disorder, which typically occurs during puberty or early adulthood. The pathogenesis of HS is complex and multifactorial; a close interaction between hormonal, genetic, epigenetics factors, host-specific aspects, and environmental influences contributes to the susceptibility, onset, severity, and clinical course of this disease, although the exact molecular mechanisms are still being explored. Epigenetics is currently emerging as an interesting field of investigation that could potentially shed light on the molecular intricacies underlying HS, but there is much still to uncover on the subject. The aim of this work is to provide an overview of the epigenetic landscape involved in HS. Specifically, in this in-depth review we provide a comprehensive overview of DNA methylation/hydroxymethylation, histone modifications, and non-coding RNAs (such as microRNA—miRNA-132, miRNA-200c, miRNA-30a-3p, miRNA-100-5b, miRNA-155-5p, miRNA-338-5p) dysregulation in HS patients. An interesting element of epigenetic regulation in HS is that the persistent inflammatory milieu observed in HS lesional skin could be exacerbated by an altered methylation profile and histone acetylation pattern associated with key inflammatory genes. Deepening our knowledge on the subject could enable the development of targeted epigenetic therapies to potentially restore normal gene expression patterns, and subsequentially ameliorate, or even reverse, the progression of the disease. By deciphering the epigenetic code governing HS, we strive to usher in a new era of personalized and effective interventions for this enigmatic dermatological condition.